Sodium Hypoclorite as an Antibacterial Agent Prior to Pulpotomies
Launched by IZMIR KATIP CELEBI UNIVERSITY · Feb 12, 2020
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
The procedure and possible discomforts, risks, and benefits had been fully explained to the parents of the children, and informed consent forms were signed.
A total of 64 children (37 boys and 27 girls), between six to 10 years old (mean=8.2 years old) who had at least two mandibular primary molars with nearly equal carious involvement that required pulpotomy were included in the study. Following anesthesia and rubber dam isolation, the pulpotomy procedure was realized. After amputation of the coronal pulp tissue, pulpal hemorrhage was controlled using dry sterile cotton pellets under slig...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Each child had at least two previously untreated lower 2nd primary mandibular molars with nearly equal carious involvement that required pulpotomies but showed positive response to vitality tests (electrical pulp test and cold stimulation)
- • The children were healthy and cooperative
- • Moderate response to chemical and thermal stimuli.
- • Teeth would be restorable with stainless steel crowns.
- Exclusion Criteria:
- • Signs of irreversible pulpitis (such as spontaneous pain, prolonged pain response),
- • Presence of percussion or palpation,
- • Pathological mobility,
- • Infectious symptoms such as fistula or abscess,
- • Discoloration in the clinical examination,
- • Presence of radiolucency in the furcation or periodical regions thickening of the periodontal spaces
- • Internal or external root resorption.
About Izmir Katip Celebi University
Izmir Katip Celebi University is a prominent academic institution in Turkey, dedicated to advancing medical research and education. The university is committed to fostering innovation and excellence in clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of experienced researchers and healthcare professionals. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Izmir Katip Celebi University actively engages in collaborative research initiatives, aiming to address critical health challenges through rigorous scientific inquiry and ethical practices in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials